The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety of second-line therapy with serplulimab, lenvatinib, and paclitaxel in patients with gastric or gastroesophageal junction adenocarcinoma (GC/GEJC) for whom immunochemotherapy failed: A multicenter, single-arm, phase II trial (STILL).
 
Song Li
No Relationships to Disclose
 
Li Meng
No Relationships to Disclose
 
Haiyan Liu
No Relationships to Disclose
 
Shifeng Kan
No Relationships to Disclose
 
Lei Cong
No Relationships to Disclose
 
Zhen Li
No Relationships to Disclose
 
Zimin Liu
No Relationships to Disclose
 
Xiaomei Xu
No Relationships to Disclose
 
Wenfei Han
No Relationships to Disclose
 
Jian Wang
No Relationships to Disclose
 
Yunxia Chu
No Relationships to Disclose
 
Cuihua Yi
No Relationships to Disclose
 
Lian Liu
No Relationships to Disclose